XML 33 R23.htm IDEA: XBRL DOCUMENT v3.25.2
Revenue (Tables)
 6 Months Ended
Jun. 29, 2025
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue [Table Text Block]
Disaggregated revenue by primary geographical markets and major goods and service lines are as follows:
Reportable Segments
Three Months Ended
June 29, 2025June 30, 2024
Life SciencesDiagnosticsTotalLife SciencesDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$197,071 $126,509 $323,580 $189,790 $117,993 $307,783 
Europe84,298 119,334 203,632 74,552 110,036 184,588 
Asia84,529 108,543 193,072 84,183 115,131 199,314 
$365,898 $354,386 $720,284 $348,525 $343,160 $691,685 
Major goods/service lines
Life Sciences Solutions$298,052 $— $298,052 $297,782 $— $297,782 
Software67,846 — 67,846 50,743 — 50,743 
Immunodiagnostics— 218,818 218,818 — 213,252 213,252 
Reproductive health— 135,568 135,568 — 129,908 129,908 
$365,898 $354,386 $720,284 $348,525 $343,160 $691,685 

Reportable Segments
Six Months Ended
June 29, 2025June 30, 2024
Life SciencesDiagnosticsTotalLife SciencesDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$381,350 $246,859 $628,209 $366,367 $235,770 $602,137 
Europe160,320 225,104 385,424 152,008 211,142 363,150 
Asia164,623 206,790 371,413 166,664 209,654 376,318 
$706,293 $678,753 $1,385,046 $685,039 $656,566 $1,341,605 
Major goods/service lines
Life Sciences Solutions$584,505 $— $584,505 $589,394 $— $589,394 
Software121,788 — 121,788 95,645 — 95,645 
Immunodiagnostics— 416,380 416,380 — 401,913 401,913 
Reproductive health— 262,373 262,373 — 254,653 254,653 
$706,293 $678,753 $1,385,046 $685,039 $656,566 $1,341,605